Amphastar Pharmaceuticals, Inc. (AMPH)

27.98 +0.24 (+0.88%) USD  |  NASDAQ  |  Jan 12, 09:33
More

Amphastar Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for AMPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Pfizer Inc. Upgrade
CorMedix, Inc. Upgrade